Completed PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT01204528

Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease (SOLID)

Diastolic Dysfunction, Microcirculation Disturbance, Sympathetic Activation and Inflammation in Moderate Kidney Failure and in Diabetic Nephropathy: Disease Modification With Vitamin-D Receptor Activation. A Double-blind, Placebo-controlled, Randomised Trial - the SOLID Trial

Sponsor: Abbott

Conditions Chronic Kidney Disease

Interventions Zemplar

Updated 5 times since 2017 Last updated: Sep 4, 2013 Started: Sep 30, 2010 Primary completion: Jun 30, 2013 Completion: Jul 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Chronic Kidney Disease, this trial is completed. The trial is conducted by Abbott and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott
Danderyd Hospital

Data source: Danderyd Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Danderyd, Sweden